DCK and acute lymphoblastic leukemia: The ratio of the IC50 of Ara‐C divided by that of clofarabine was significantly higher in cell lines with relatively lower rather than higher DCK gene expression, demonstrating that the antileukemic activity of clofarabine is relatively more potent in BCP‐ALL cells with relatively lower DCK gene expression.